Benzinga | May 3, 2021 11:11AM EDT

NLS Pharma European Patent Office Abstract For Co.'s 'A MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)'

https://register.epo.org/application?number=EP17724102